198 related articles for article (PubMed ID: 7946551)
1. Erythropoietin in very preterm infants.
Fernandes CJ; Hagan R; Frieberg A; Grauaug A; Kohan R
J Paediatr Child Health; 1994 Aug; 30(4):356-9. PubMed ID: 7946551
[TBL] [Abstract][Full Text] [Related]
2. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
Dallman PR
Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
[No Abstract] [Full Text] [Related]
3. Role of rHuEpo on blood transfusions in preterm infants after the fifteenth day of life.
Testa M; Reali A; Copula M; Pinna B; Birocchi F; Pisu C; Chiappe F
Pediatr Hematol Oncol; 1998; 15(5):415-20. PubMed ID: 9783307
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.
Giannakopoulou C; Bolonaki I; Stiakaki E; Dimitriou H; Galanaki H; Hatzidaki E; Kalmanti M
Pediatr Hematol Oncol; 1998; 15(1):37-43. PubMed ID: 9509504
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
6. Role of erythropoietin in the newborn.
Emmerson AJ
Arch Dis Child; 1993 Sep; 69(3 Spec No):273-5. PubMed ID: 8215563
[No Abstract] [Full Text] [Related]
7. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era.
Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K
Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976
[TBL] [Abstract][Full Text] [Related]
8. Avoidance of red blood cell transfusion in an extremely preterm infant given recombinant human erythropoietin therapy.
Yu VY; Bacsain MB
J Paediatr Child Health; 1994 Aug; 30(4):360-2. PubMed ID: 7946552
[TBL] [Abstract][Full Text] [Related]
9. Recombinant erythropoietin and blood transfusion in selected preterm infants.
Meyer MP; Sharma E; Carsons M
Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F41-5. PubMed ID: 12496225
[TBL] [Abstract][Full Text] [Related]
10. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
[TBL] [Abstract][Full Text] [Related]
11. Anaemia of prematurity. Epidemiology, management and costs.
Meyer MP
Pharmacoeconomics; 1997 Oct; 12(4):438-45. PubMed ID: 10174310
[TBL] [Abstract][Full Text] [Related]
12. Recombinant erythropoietin in very-low-birth-weight infants.
Beck D; Calame A; Masserey E
N Engl J Med; 1994 Sep; 331(10):676-7; author reply 677-8. PubMed ID: 8052281
[No Abstract] [Full Text] [Related]
13. [-Development and evaluation of transfusion practices in a population of newborn infants less than 33 weeks gestational age].
Pierrat V; Lequien P
Arch Pediatr; 1998 Mar; 5(3):341-2. PubMed ID: 10328009
[No Abstract] [Full Text] [Related]
14. Recombinant erythropoietin in very-low-birth-weight infants.
Carnielli VP; Da Riol R; Montini G
N Engl J Med; 1994 Sep; 331(10):677; author reply 677-8. PubMed ID: 8052282
[No Abstract] [Full Text] [Related]
15. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study.
Arif B; Ferhan K
Pediatr Int; 2005 Feb; 47(1):67-71. PubMed ID: 15693870
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
[TBL] [Abstract][Full Text] [Related]
18. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
Ohls RK; Christensen RD
J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
[TBL] [Abstract][Full Text] [Related]
19. Current controversies in the management of the anemia of prematurity.
Bishara N; Ohls RK
Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
[TBL] [Abstract][Full Text] [Related]
20. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.
Ohls RK; Ehrenkranz RA; Wright LL; Lemons JA; Korones SB; Stoll BJ; Stark AR; Shankaran S; Donovan EF; Close NC; Das A
Pediatrics; 2001 Oct; 108(4):934-42. PubMed ID: 11581447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
